Continuum (Minneapolis, Minn.)HumansDrug DevelopmentGenetic TherapyRare Diseases
Safety, Costs, and Ethical Issues in Drug Development and Gene Therapy for Rare Diseases.
Nicholas Johnson, A Gordon Smith
Published: 202510.1212/cont.0000000000001619
Abstract
Scientific advances have provided the ability to modify the course of genetic diseases through the use of genetic therapies. These therapies include RNA-based approaches that either reduce the translation of a toxic protein or skip exons to produce a…
Preview only. Read the full abstract at the source